
|Articles|February 26, 2022
Cardiology Month in Review: February 2022
Advertisement
Editor's Note: Clicking in the center of the slide will redirect you to the affiliated article or video.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D
3
What Comes Next for Berobenatide? VESPER-3 and Phase 3 Expectations, With John Buse, MD, PhD
4
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
5


























































